FDA's evaluation concluded that the criteria weighed against placement on the list, citing inadequate physicochemical characterization, immunogenicity concerns from impurities and aggregates, lack of clinical effectiveness data for any approved use, and absence of published human exposure data for the proposed subcutaneous and topical routes
Treatment starts at 2.5 mg and increases by 2.5 mg every four weeks until reaching the maximum tolerated dose
Effects of intracerebroventricular MOTS-c infusion on thyroid hormones and uncoupling proteins
According to FDA regulations for compounded drugs, these versions should be produced only by licensed compounding pharmacies and used only when prescribed by a professional healthcare provider to meet a patients medical needs
The resolution of supply shortages comes as lawsuits against Novo Nordisk continue to escalate
Of note, in the evoke/evoke+ trials, computerized tomography (CT) scan could be performed if magnetic resonance imaging (MRI) was contraindicated or not available, allowing for wider patient involvement
